Atlas Trials

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

Clinical trial NCT03531632 · COMPLETED

Trial details

NCT number
NCT03531632
Sponsor
MacroGenics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2018-06-04
Primary completion
2020-02-08
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.